Stock JULPHAR GULF PHARMACEUTICAL INDUSTRIES
Add to a list
To use this feature you must be a member
Log inSign up

Company Gulf Pharmaceutical Industries

Equities

JULPHAR

AEG000201018

Pharmaceuticals

Market Closed - Abu Dhabi Securities Exchange
Other stock markets
 06:55:00 2024-04-24 am EDT 		5-day change 1st Jan Change
0.944 AED -0.63% Intraday chart for Gulf Pharmaceutical Industries -1.97% +22.76%
Mar. 21 Gulf Pharmaceutical Industries Shares to be Suspended Ahead of Annual General Meeting MT
Mar. 15 Abu Dhabi's Gulf Pharmaceutical Industries Resumes Trading Following FY23 Results Publication MT

Business Summary

Gulf Pharmaceutical Industries PSC (Julphar) is a United Arab Emirates-based public shareholding company engaged in manufacturing and selling of medicines, drugs and other types of pharmaceutical and medical compounds, in addition to cosmetic compounds. The Company maintains a range of product portfolio, which target major therapeutic segments, including endocrinology, anti-infective, cardiovascular and gastroenterology, over-the-counter, nephrology, dermatology, respiratory, metabolic and burn and wound management. The Company operates through a network of more than 10 manufacturing plants, and a logistics network. The Company has approximately 800 products in various dosage forms, and more in the pipeline. The Company’s subsidiaries include Mena Cool FZE, which is engaged in the transportation, and Julphar Pharmaceuticals PLC, which is engaged in Manufacturing of medicines, wrapping and packing materials.

Number of employees: 2,400

Sales per Business

AED in Million2022Weight2023Weight Delta
Planet
65.2 %
1,005 62.2 % 1,067 65.2 % +6.16%
Manufacturing
48.5 %
611 37.8 % 794 48.5 % +30.06%
Eliminations
-13.7 %
- - -224 -13.7 % -

Sales per region

AED in Million2022Weight2023Weight Delta
United Arab Emirates
37.1 %
573 35.5 % 608 37.1 % +6.12%
Saudi Arabia
34.0 %
202 12.5 % 558 34.0 % +175.44%
Others
21.0 %
714 44.2 % 344 21.0 % -51.77%
Oman
7.8 %
127 7.9 % 128 7.8 % +0.87%

Managers

Managers TitleAgeSince
Basel Ziyadeh CEO
 Chief Executive Officer - -
Ignacio Anglada DFI
 Director of Finance/CFO - -
Malik Metahri CTO
 Chief Tech/Sci/R&D Officer - -
Hessa Al-Shehhi IRC
 Investor Relations Contact - -
Ali Aqel PRN
 Corporate Officer/Principal - 17-10-31
Juergen Lauterbach PRN
 Corporate Officer/Principal - 19-09-30
Gopa Kumar HRO
 Human Resources Officer - -

Members of the board

Members of the board TitleAgeSince
Rabih Khouri BRD
 Director/Board Member - 21-07-31
Abdulaziz Al-Zaabi BRD
 Director/Board Member - 16-12-31
Jean Diab BRD
 Director/Board Member - 22-12-31
Medhat Abo Al Asrar BRD
 Director/Board Member - 18-12-31
Sheikh Saqer Al-Qassimi CHM
 Chairman - 04-12-31
Raman Garg BRD
 Director/Board Member - 19-12-31
Abboud Bejjani BRD
 Director/Board Member - 19-12-31
Olfa Gam BRD
 Director/Board Member - 21-07-31
Hamodi Ali Limy BRD
 Director/Board Member - 21-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,155,227,811 355,337,677 ( 30.76 %) 0 30.76 %

Shareholders

NameEquities%Valuation
Middle East Pharma Investment
24.05 %
277,779,148 24.05 % 72 M AED
Emirate of Ras Al Khaimah (United Arab Emirates)
12.24 %
141,399,884 12.24 % 37 M AED
Arab Company for Drug Industries & Medical Appliances
9.151 %
105,713,741 9.151 % 27 M AED
Yaser Naghi
9.000 %
103,970,502 9.000 % 27 M AED
Muhairi Mohamed Abdulaziz Rabie Shahin Al
7.574 %
87,499,984 7.574 % 23 M AED
Faisal Saqr bin Mohammed Al-Qasimi
7.178 %
82,918,786 7.178 % 21 M AED
DFA Australia Ltd.
0.000888 %
10,264 0.000888 % 2 658 AED

Company contact information

Gulf Pharmaceutical Industries

Airport Road Digdaga

, Ras Al Khaymah

+

http://www.julphar.net
address Gulf Pharmaceutical Industries(JULPHAR)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per Business

Sales per region

Ratings for Gulf Pharmaceutical Industries

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
0.95 AED
Average target price
0.72 AED
Spread / Average Target
-24.21%
Consensus

Annual profits - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
GULF PHARMACEUTICAL INDUSTRIES Stock Gulf Pharmaceutical Industries
+24.06% 299M
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+11.94% 9.18B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-16.33% 4.79B
YUHAN CORPORATION Stock Yuhan Corporation
+6.40% 3.97B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+26.98% 3.98B
INDIVIOR PLC Stock Indivior PLC
+28.27% 2.56B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-26.55% 2.29B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-25.02% 2.23B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+5.82% 1.92B
VELOXIS PHARMACEUTICALS A/S Stock Veloxis Pharmaceuticals A/S
-0.50% 1.64B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. JULPHAR Stock
  4. Company Gulf Pharmaceutical Industries